Berger Franklin M
- SEC CIK
- 0001273885
No open-market purchases or sales filed in the past year.
Current role at each company
- AVIR Atea Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- KZR Kezar Life Sciences, Inc.Directoras of May 11, 2026
- EPIX ESSA Pharma Inc.Directoras of Oct 15, 2025
- Rain Oncology Inc.Directoras of Jan 26, 2024
- BCEL Atreca, Inc.Directoras of Jun 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Berger Franklin M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVIR Atea Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 (view filing) | Jan 15-16 | 2 days | Berger Franklin MDirector | PPurchase | +25.0K | $3.26 | +$81.5K | +5.5%476.9K after | Amended2 lots |
| Dec 12, 2024 (view filing) | Dec 10 | 2 days | Berger Franklin MDirector | SSale | −359.6K | $2.85 | −$1.02M | −44.3%451.9K after | |
| Nov 15, 2022 (view filing) | Nov 11-14 | 4 days | Berger Franklin MDirector | SSale | −41.7K | $5.15 | −$214.7K | −5.1%778.4K after | 2 lots |
EPIX ESSA Pharma Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 (view filing) | Nov 21 | 1 day | Berger Franklin MDirector | PPurchase | +23.3K | $5.73 | +$133.3K | +3.1%784.4K after | |
| Nov 16, 2023 (view filing) | Nov 2-3 | 14 daysLate | Berger Franklin MDirector | PPurchase | +76.5K | $5.49 | +$419.7K | +11.2%760.9K after | 2 lots |
| Jan 5, 2023 (view filing) | Dec 14-21, 2022 | 22 daysLate | Berger Franklin MDirector | SSale | −272.8K | $2.67 | −$729.1K | −28.5%684.4K after | 7 lots |
Rain Oncology Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 (view filing) | Nov 21-22 | 2 days | Berger Franklin MDirector | PPurchase | +122.0K | $8.10 | +$987.8K | +13.8%1.01M after | 2 lots |
| Nov 14, 2022 (view filing) | Nov 8 | 6 daysLate | Berger Franklin MDirector | PPurchase | +42.9K | $5.83 | +$250.0K | +5.1%883.2K after | |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Berger Franklin MDirector | PPurchase | +3.79K | $14.30 | +$54.1K | +0.5%840.3K after |
KZR Kezar Life Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 (view filing) | Mar 18-21 | 4 days | Berger Franklin MDirector | PPurchase | +80.0K | $16.25 | +$1.30M | +9.9%890.7K after | 3 lots |